India's pharma sector must shift from cost competitiveness to innovation, global quality: Experts

For the growth of India's pharmaceutical sector, prioritizing innovation and advanced manufacturing is essential. Experts indicate that increasing investments in research and digital technologies could propel the market to an impressive USD 130 billion by 2030. Companies must also elevate their quality and comply with global regulatory expectations to compete in the global landscape, thus establishing India as an innovation hub in life sciences.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ILvMO8R
via IFTTT